CN103751403A - Traditional Chinese medicine composition for treating cholinergic urticaria - Google Patents

Traditional Chinese medicine composition for treating cholinergic urticaria Download PDF

Info

Publication number
CN103751403A
CN103751403A CN201410012849.0A CN201410012849A CN103751403A CN 103751403 A CN103751403 A CN 103751403A CN 201410012849 A CN201410012849 A CN 201410012849A CN 103751403 A CN103751403 A CN 103751403A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
radix
cholinergic urticaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410012849.0A
Other languages
Chinese (zh)
Other versions
CN103751403B (en
Inventor
戴彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dai Bin
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410012849.0A priority Critical patent/CN103751403B/en
Publication of CN103751403A publication Critical patent/CN103751403A/en
Application granted granted Critical
Publication of CN103751403B publication Critical patent/CN103751403B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a traditional Chinese medicine composition for treating cholinergic urticaria. The traditional Chinese medicine composition is characterized by being prepared from the following components in parts by weight: 5 to 12 parts of schizonepeta, 5 to 12 parts of radix saposhnikoviae, 3 to 10 parts of periostracum cicada, 5 to 12 parts of cortex phellodendri, 5 to 15 parts of fructus forsythia, 10 to 40 parts of plaster stone, 5 to 15 parts of radix sophorae flavescentis, 5 to 15 parts of cortex dictamni, 3 to 10 parts of rhizoma cimicifugae, 5 to 12 parts of scutellaria baicalensis, 5 to 20 parts of radix rehmanniae, 5 to 15 parts of cortex moutan, and 3 to 8 parts of liquorice; and the components above can be prepared into any one of the forms of decoction, granules, pills or capsules by the general method of a traditional Chinese medicine preparation. The traditional Chinese medicine composition focuses on the optimization of effects of the components on clearing heat and removing toxicity, and dispelling wind and arresting itching, so as to specially treat adverse clinical symptoms of cholinergic urticaria; and with the coordinative action of all the components, the traditional Chinese medicine has the effects of accelerating the adequate eruption of cholinergic urticaria, dispersing and promoting eruption, eliminating wind and relieving convulsion, clearing away heat and drying dampness, nourishing Yin and engendering liquid, balancing internal environment, and particularly reducing hazardous substances in blood, so as to remove toxin from blood to the body surface along with sweat, and as a result, the cholinergic urticaria can be treated completely.

Description

A kind of Chinese medicine composition for the treatment of cholinergic urticaria disease
Technical field
The present invention relates to a kind of smelting and treat the medicine of urticaria, the Chinese medicine composition of cholinergic urticaria disease is treated in especially a kind of smelting.
Background technology
Cholinergic urticaria is to be heated when human body, psychentonia, take in hot food or beverage, or body temperature slightly increases after motion, the blood flow of the gain of heat stimulates brain thermotaxic centre, and excited cholinergy is neural, and discharge acetylcholine, if irritated to this chemical substance of acetylcholine, can there is anaphylaxis, the symptom that people cause this allergy is referred to as the active urticaria of choline.This anaphylactoid reaction, except without erythra, only has outside the acute gargalesthesia of twinge, also can occur 2 red millimeter welts at trunk and limbs near-end skin, and this welt speed is carried out fast going, and leaves no trace.Whole process be several months to the several years not etc.Doctor trained in Western medicine there is no specific short to cholinergic urticaria at present, and for many Bian, antihistamine drug for oral administration, corticosteroids medicine suppress the symptom of cholinergic urticaria disease, separately by Xian's agent, Emulsion, mud cream, ointment etc., embrocate affected part, in order to alleviate disease.Above-mentioned treatment can only be to take stopgap measures, and does not effect a permanent cure, and patient often presents outbreak repeatedly.In recent years, someone studies and uses traditional Chinese medicine composition for treating cholinergic urticaria, as Chinese patent CN103393802 discloses the oral medicine of following traditional Chinese medicines component and weight portion; Herba Ephedrae 6-9, Radix Salviae Miltiorrhizae 6-9, Radix Sophorae Flavescentis 6-9, Fructus Cnidii 6-9, Radix Saposhnikoviae 6-9, Cortex Dictamni 3-5, Fructus Kochiae 3-5, Herba Lysimachiae 3-5, Herba Lysimachiae 3-5, Periostracum Cicadae 3-5, fry flying worm 3-5, Radix Gentianae Macrophyllae 3-5, Spina Gleditsiae 3-5, Flos Lonicerae 2-4, Fructus Forsythiae 2-4, Herba Portulacae 2-4, Fructus Atriplicis Sibiricae 2-4, leaf of Semen Juglandis 2-4, Radix Glycyrrhizae 2-4.Except above-mentioned oral medicine, still need and embrocate affected part with the Chinese medicine lotion for external use that following component and weight fraction form; Linum 6-9, Radix Rehmanniae 6-9, Fructus Gardeniae (parched to brown) 6-9 , Herba Siegesbeckiae 6-9, Radix Arnebiae (Radix Lithospermi) 2-4, Herba Menthae 2-4, Flos Chrysanthemi Indici 2-4, Herba Lycopi 2-4, comb Folium Cannabis 2-4, Folium Isatidis 2-4, Oleum sesami 5-10.The above-mentioned Chinese medicine composition complexity of not only filling a prescription, for oral administration and external of still needing starts at the same time, and therapeutic effect still can not be satisfactory.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, a kind for the treatment of both the principal and secondary aspects of a disease is provided, the Chinese medicine composition of the treatment cholinergic urticaria disease that curative effect is high.Object of the present invention realizes by following technical proposals: a kind of Chinese medicine composition for the treatment of cholinergic urticaria disease, formulated by following component and weight portion: Herba Schizonepetae 5-12, Radix Saposhnikoviae 5-12, Periostracum Cicadae 3-10, Cortex Phellodendri 5-12, Fructus Forsythiae 5-15, Gypsum Fibrosum 10-40, Radix Sophorae Flavescentis 5-15, Cortex Dictamni 5-15, Rhizoma Cimicifugae 3-10, Radix Scutellariae 5-12, Radix Rehmanniae 5-20, Cortex Moutan 5-15, Radix Glycyrrhizae 3-8, above-mentioned each component by Chinese medicine preparation conventional method make decoction, electuary, pill or oral capsule any.
The present invention utilizes traditional Chinese medicine theoretical direction of science, through concentrating on studies for many years, obtains with clinical practice.The present invention mainly concentrates and optimizes heat-clearing and toxic substances removing in component, dispelling wind for relieving itching function, in order to the bad clinical symptoms of symptomatic treatment cholinergic urticaria, and by the coordinative role in each component medicine, accelerate measles and thoroughly send out, declare loose rash, endogenous wind stopping relieving convulsion, heat clearing and damp drying, YIN nourishing and the production of body fluid promoting, balance human internal environment, especially reduces nuisance in blood, thereby make the toxin in blood discharge body surface with antiperspirant, fundamentally treat this disease.The compatibility of each component of the present invention is rigorous proper, reasonable recipe, the effect of each component medicine is: if Herba Schizonepetae, windproof garment expelling pathogenic wind from the body surface function sends out not smooth for measles thoroughly, energy dispelling wind for relieving itching, the loose rash of a surname, Periostracum Cicadae is mainly dispelling wind heat, rash, endogenous wind stopping relieving convulsion function, above three medicines can be given full play to adjustment organismic internal environment function, coordinate the five internal organs, in the present invention as monarch drug.Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication, Fructus Forsythiae heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, the clear part of the body cavity above the diaphragm housing the heart and lungs heat of two medicines, Cortex Phellodendri is mainly heat clearing and damp drying, eliminating fire and detoxication, reducing the asthenic fever, Rhizoma Cimicifugae is delivered rash, heat-clearing and toxic substances removing, ascending up spleen-Qi and Yang, above-mentioned four medicines all have the merit of removing toxic substances, as ministerial drug.Cortex Dictamni heat-clearing and toxic substances removing, removing damp to relieve itching, eliminating fire and detoxication, Gypsum Fibrosum clearing away heat-fire, relieving restlessness only exhausts, Radix Sophorae Flavescentis heat clearing and damp drying, wind dispelling insecticide, diuresis, upper three components are as adjuvant drug, Radix Rehmanniae clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, Cortex Moutan clearing away heat and cooling blood, promoting blood circulation to remove blood stasis (is controlled wind and is first controlled blood, blood wind is from going out) for making medicine, Radix Glycyrrhizae invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, relieving spasm to stop pain, relax the property of medicine, guide above-mentioned all medicines to enter blood and the five internal organs, thereby ensure medical effect of the present invention.
The present invention is through clinical application for many years, and effect is very good, and cure rate reaches 89%, and effective percentage reaches 99%, refers to table 1.
Figure 709896DEST_PATH_IMAGE001
Note: above-mentioned treatment is to be used as curative with embodiments of the invention 1 electuary.
The present invention treats case and all according to cholinergic urticaria diagnosis index, determines.
Described recovery from illness refers to that cholinergic urticaria symptom all disappears, nothing recurrence in month.
The described cholinergic urticaria symptom that effectively refers to obviously alleviates or disappears, but has recurrence in one month.
Described invalid finger cholinergic urticaria symptom is without obviously alleviating, or in one month, has twice recurrence.
Using method of the present invention: electuary every day three times, each 1 bag, decoction every day three times, each 30 milliliters, pill every day three times, each 20 grams.
The specific embodiment
Embodiment 1, and a kind of Chinese medicine composition electuary for the treatment of cholinergic urticaria disease is got the raw materials ready by following component and weight portion:
Herba Schizonepetae 5Kg, Radix Saposhnikoviae 12 Kg, Periostracum Cicadae 8 Kg, Cortex Phellodendri 5 Kg, Fructus Forsythiae 15 Kg, Gypsum Fibrosum 10 Kg, Radix Sophorae Flavescentis 10 Kg, Cortex Dictamni 15 Kg, Rhizoma Cimicifugae 3 Kg, Radix Scutellariae 10 Kg, the Radix Rehmanniae 20 Kg, Cortex Moutan 5 Kg, Radix Glycyrrhizae 8 Kg, production method, follows these steps to carry out:
1, accurately take each component standby;
2, by the 1-2 of each component total amount of Chinese medicine, doubly measure and add clean clean water, be placed in after decoction pot mixes with Chinese medicinal components and decoct into decoction;
3, concentrated; After filtering residue, decoction is concentrated into the thick paste of 1/4 weight of former dose;
4, sugaring powder was pulverized in time 40-60 mesh sieve by clean white sugar after 60 ℃ of left and right are dry, made dry Icing Sugar;
5, granule processed, gets thick paste 2 weight portions and adds Icing Sugar 2 weight portions to be placed in container, and stir into moisture state and cross 10-12 order granulation sieve, granulation, certain Icing Sugar is available dextrin or starch in replace also;
6, dry, the above-mentioned granule of making is packed after 40-70 ℃ of oven dry, every bag is 16 grams.
Embodiment 2, and a kind of Chinese medicine composition decoction for the treatment of cholinergic urticaria disease is got the raw materials ready by following component and weight portion:
Herba Schizonepetae 12Kg, Radix Saposhnikoviae 5 Kg, Periostracum Cicadae 3 Kg, Cortex Phellodendri 10 Kg, Fructus Forsythiae 5 Kg, Gypsum Fibrosum 40 Kg, Radix Sophorae Flavescentis 15 Kg, Cortex Dictamni 5 Kg, Rhizoma Cimicifugae 10 Kg, Radix Scutellariae 12 Kg, the Radix Rehmanniae 5 Kg, Cortex Moutan 15 Kg, Radix Glycyrrhizae 3 Kg, production method, follows these steps to carry out:
1, accurately take each component standby;
2, by the 1-2 of each component total amount of Chinese medicine, doubly measure and add clean clean water, be placed in after decoction pot mixes with Chinese medicinal components and decoct into decoction;
3, concentrated; After filtering residue, decoction is concentrated into the thick soup of 1/3 weight of former dose, subpackage, is advisable with every bottle or a bag 30ml.
Embodiment 3, and a kind of Chinese medicine composition pill for the treatment of cholinergic urticaria disease is got the raw materials ready by following component and weight portion:
Herba Schizonepetae 8Kg, Radix Saposhnikoviae 8 Kg, Periostracum Cicadae 10 Kg, Cortex Phellodendri 12Kg, Fructus Forsythiae 10 Kg, Gypsum Fibrosum 15 Kg, Radix Sophorae Flavescentis 5 Kg, Cortex Dictamni 10Kg, Rhizoma Cimicifugae 8 Kg, Radix Scutellariae 5Kg, the Radix Rehmanniae 15 Kg, Cortex Moutan 10 Kg, Radix Glycyrrhizae 5 Kg, production method, medicine pill producer legal system or pill routinely.

Claims (1)

1. a Chinese medicine composition for the treatment of cholinergic urticaria disease, is characterized in that, formulated by following component and weight portion: Herba Schizonepetae 5-12, Radix Saposhnikoviae 5-12, Periostracum Cicadae 3-10, Cortex Phellodendri 5-12, Fructus Forsythiae 5-15, Gypsum Fibrosum 10-40, Radix Sophorae Flavescentis 5-15, Cortex Dictamni 5-15, Rhizoma Cimicifugae 3-10, Radix Scutellariae 5-12, Radix Rehmanniae 5-20, Cortex Moutan 5-15, Radix Glycyrrhizae 3-8, above-mentioned each component by Chinese medicine preparation conventional method make decoction, electuary, pill or oral capsule any.
CN201410012849.0A 2014-01-13 2014-01-13 A kind of Chinese medicine composition for the treatment of cholinergic urticaria Active CN103751403B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410012849.0A CN103751403B (en) 2014-01-13 2014-01-13 A kind of Chinese medicine composition for the treatment of cholinergic urticaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410012849.0A CN103751403B (en) 2014-01-13 2014-01-13 A kind of Chinese medicine composition for the treatment of cholinergic urticaria

Publications (2)

Publication Number Publication Date
CN103751403A true CN103751403A (en) 2014-04-30
CN103751403B CN103751403B (en) 2015-09-30

Family

ID=50518830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410012849.0A Active CN103751403B (en) 2014-01-13 2014-01-13 A kind of Chinese medicine composition for the treatment of cholinergic urticaria

Country Status (1)

Country Link
CN (1) CN103751403B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104771706A (en) * 2015-04-26 2015-07-15 赵霞 Traditional Chinese medicine composition for treating chronic urticaria

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1259382A (en) * 1999-12-16 2000-07-12 傅广和 Dissolvable granula prepn. prepd. from forgythia fruit and honeysuckle
CN102370904A (en) * 2011-09-28 2012-03-14 邓华伦 Chinese herbal medicine for curing chicken poxes
CN102416127A (en) * 2011-12-09 2012-04-18 崔国志 Chinese medicinal powder for treating psoriasis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1259382A (en) * 1999-12-16 2000-07-12 傅广和 Dissolvable granula prepn. prepd. from forgythia fruit and honeysuckle
CN102370904A (en) * 2011-09-28 2012-03-14 邓华伦 Chinese herbal medicine for curing chicken poxes
CN102416127A (en) * 2011-12-09 2012-04-18 崔国志 Chinese medicinal powder for treating psoriasis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104771706A (en) * 2015-04-26 2015-07-15 赵霞 Traditional Chinese medicine composition for treating chronic urticaria

Also Published As

Publication number Publication date
CN103751403B (en) 2015-09-30

Similar Documents

Publication Publication Date Title
CN103110844B (en) Traditional Chinese medicine for treating acute tonsillitis
CN101874867A (en) Chinese medicinal preparation for treating psoriasis
CN104984316A (en) Medicine for treating female cold in uterus
CN101912567B (en) Chinese medicinal prescription for treating chronic myocarditis
CN106668631A (en) Chinese herbal medicine for treating rhinitis
CN102198234A (en) Chinese herbal medicine preparation for treating acute viral myocarditis accompanied by bowel sepsis
CN105079400A (en) Pharmaceutical preparation for treating osteoporosis
CN102100817A (en) Chinese medicinal preparation for treating infection of upper respiratory tracts
CN1097621A (en) Anti-cancer powder
CN103751403B (en) A kind of Chinese medicine composition for the treatment of cholinergic urticaria
CN104173727A (en) Medicine for treating toothache
CN104337994A (en) Medicine for treating digestive tract cancers
CN102600387A (en) Chinese herbal medicinal preparation for treating acute viral myocarditis complicated with enterotoxaemia
CN101239140A (en) Chinese medicine for treating psoriasis
CN103120768A (en) Medicament for treating vital myocarditis and cardiomyopathy
CN104784559A (en) Traditional Chinese medicine preparation for treating postcholecystectomy syndrome
CN104906472A (en) Traditional Chinese medicine composition for preventing and treating cough-variant asthma
CN103006950A (en) Traditional Chinese medicine for treating pharyngolaryngitis and preparation process thereof
CN103127417A (en) Drug for curing nasosinusitis and preparation method thereof
CN101983712A (en) Novel medicament for treating coronary heart disease
CN102266537B (en) Chinese prepared medicine for treating chronic gastritis and gastroduodenal ulcer and preparation method thereof
CN105055835A (en) Traditional Chinese medicine composition used for treating female menopausal syndrome
CN103721154A (en) Traditional Chinese medicinal preparation for treating gastrointestinal diseases and preparation method of traditional Chinese medicinal preparation
CN105233162A (en) Traditional Chinese medicine composition for treating chronic cholecystitis, and preparation method and pharmaceuticals thereof
CN104587035A (en) Medicine composition for treating oral ulcer and preparation method for medicine composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20180730

Address after: 610041 Sichuan Province China (Sichuan) Free Trade Test Zone

Patentee after: Chengdu Si Tang Tang Medicine Technology Co., Ltd.

Address before: 637400 Langzhong City, Nanchong, Sichuan, govern the people's Government of Pingxiang.

Patentee before: Dai Bin

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220323

Address after: 637000 Zhiping Township People's Government of Langzhong City, Nanchong City, Sichuan Province

Patentee after: Dai Bin

Address before: 610041 Sichuan Province China (Sichuan) Free Trade Test Zone

Patentee before: Chengdu Si Tang Tang Medicine Technology Co.,Ltd.

TR01 Transfer of patent right